Percutaneous coronary intervention of unprotected left main disease: Five-year outcome of a single-center registry

Wijns, 2010, Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery, Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277 Huang, 2006, Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), Catheter Cardiovasc Interv, 68, 867, 10.1002/ccd.20886 Park, 2011, Randomized trial of stents versus bypass surgery for left main coronary artery disease, N Engl J Med, 364, 1718, 10.1056/NEJMoa1100452 Serruys P. The 4-year outcomes of the SYNTAX trial in the subset of patients with left main disease. TCT 2011. Park, 2010, J Am Coll Cardiol, 56, 117, 10.1016/j.jacc.2010.04.004 Thygesen, 2007, Universal definition of myocardial infarction, Eur Heart J, 28, 2525, 10.1093/eurheartj/ehm355 Mehilli, 2009, ISAR-LEFT-MAIN (Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions) Study Investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease, J Am Coll Cardiol, 53, 1760, 10.1016/j.jacc.2009.01.035 Biondi-Zoccai, 2008, A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease, Am Heart, 155, 274, 10.1016/j.ahj.2007.10.009 Palmerini, 2008, Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology, Am J Cardiol, 11, 1463, 10.1016/j.amjcard.2008.07.030 Meliga, 2009, Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT), Int J Cardiol, 137, 16, 10.1016/j.ijcard.2008.06.006 Tan, 2001, Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients, Circulation, 104, 1609, 10.1161/hc3901.096669 Lozano, 2011, Left main stenting: don’t forget the angiographic follow-up, EuroIntervention, 6, 904, 10.4244/EIJV6I7A156 Brennan, 2012, Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States. A report from the National Cardiovascular Data Registry, 2004 to 2008, J Am Coll Cardiol, 59, 648, 10.1016/j.jacc.2011.10.883 Kim, 2009, Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents, Circulation, 120, 400, 10.1161/CIRCULATIONAHA.108.800805 Montalescot, 2009, Unprotected left main revascularization in patients with acute coronary syndromes, Eur Heart J, 30, 2308, 10.1093/eurheartj/ehp353 Pappalardo, 2011, Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction, JACC Cardiovasc Interv, 4, 618, 10.1016/j.jcin.2011.02.016 Chieffo, 2012, Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment, JACC Cardiovasc Interv, 5, 718, 10.1016/j.jcin.2012.03.022 Lee, 2012, Percutaneous coronary intervention of unprotected left main coronary artery disease: procedural strategies and technical considerations, Catheter Cardiovasc Interv, 79, 812, 10.1002/ccd.23042